scholarly journals TCT-32 First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions

2013 ◽  
Vol 62 (18) ◽  
pp. B11 ◽  
Author(s):  
Bernard Chevalier
Sign in / Sign up

Export Citation Format

Share Document